Shares of Walgreen Boots Alliance and Rite Aid tumbled on Friday, after the merger of the two drugstore companies faced reported resistance from US antitrust regulators.
Walgreens shares ended the session down by about 2 percent and Rite Aid shares plunged by more than 13 percent.
Walgreens said in September it would divest between 500 and 1,000 stores to help get cleared by the Federal Trade Commission for a $9.4 billion deal to acquire Rite Aid, according to Reuters. However, reports say the antitrust regulators will not accept this concession.
The merger agreement was previously scheduled to be completed on October 27, 2016 but was delayed until January 27.
Walgreens is the largest US retail pharmacy chain by locations and is looking to buy Rite Aid to further expand its brand across the country and to have more leverage in drug price negotiations.
Rite Aid did not immediately respond to a request for comment by CNBC. Walgreen’s representatives declined to comment.
Full Content: CNBC
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Urged to Enforce Rarely Used Antitrust Law Against Retail Giants
Mar 28, 2024 by
CPI
UK’s Fingleton Bolsters Team with New Additions
Mar 28, 2024 by
CPI
Britain’s Competition Regulator Clears Aviva’s Acquisition of AIG Life UK
Mar 28, 2024 by
CPI
White House Implements New AI Safeguards to Protect Rights and Safety
Mar 28, 2024 by
CPI
Denver Court Sets August Date for Kroger-Albertsons Merger Showdown
Mar 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Real Estate & Antitrust
Mar 27, 2024 by
CPI
Systematic National Evidence of Steering by Real Estate Agents
Mar 27, 2024 by
CPI
Compliance Now! Actionable Antitrust Advice for the Residential Real Estate Industry
Mar 27, 2024 by
CPI
Real Estate Commissions: Some Insights from the Economics of Multi-Sided Platforms
Mar 27, 2024 by
CPI
New Ideas for Promoting Real Estate Brokerage Price Competition
Mar 27, 2024 by
CPI